Cold Spring Harbor Laboratory

Cold Spring Harbor Laboratory, a tax-exempt non-profit research and education institution headquartered in Cold Spring Harbor, New York, operates as a prime recipient and occasional subrecipient on federal research grants across the life sciences, with 95% of its 816 awards in the source data as prime grants. CSHL does not hold federal contracts; it competes entirely through grant mechanisms—primarily project grants and conference support—with no set-aside posture applicable.

CSHL's portfolio is dominated by federal research grant funding from the National Institutes of Health, the National Science Foundation, and the Defense Health Agency. The institution conducts investigator-initiated basic and applied biomedical research across cancer biology, neuroscience, genomics, developmental biology, and plant science, supplemented by a substantial meetings and courses program funded through NIH and NSF mechanisms. Core capabilities include structural and functional neurobiology (MAPseq and BARseq brain connectivity mapping, whole-cell patch-clamp electrophysiology, two-photon imaging), cancer cell biology and immunology (metabolic reprogramming, tumor microenvironment interactions, immune checkpoint mechanisms), comparative genomics and quantitative genetics, single-cell and spatial transcriptomics, and computational biology. The institution operates the Cold Spring Harbor Laboratory DNA Learning Center, which develops bioinformatics workforce training, undergraduate research experiences in DNA sequencing, and high school outreach programs targeting underrepresented groups.

CSHL's grant funding concentration reflects its dual mission of research and education. The National Institutes of Health National Cancer Institute alone accounts for 91 awards (combined potential value $28 thousand), while NIH's National Institute on Drug Abuse carries the largest single award magnitude at $115 thousand potential value across nine grants. The National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, and National Institute on Deafness and Other Communication Disorders represent major neuroscience and aging research supporters. The National Science Foundation funds plant biology research, bioinformatics curriculum development, workforce diversity initiatives, and workforce training programs under the Division of Undergraduate Education and Biological Sciences programs. The Defense Health Agency funds military-relevant cancer and neuroscience research through its Military Medical Research and Development program (CFDA 12.420).

Representative grant work spans: $2.77 million from the National Institute on Deafness and Other Communication Disorders to investigate how social odor cues modulate auditory cortex via the basal amygdala; $1.75 million from the NIH Office of the Director to study speckle-based gene regulation mechanisms; $1.44 million from the Defense Health Agency to target hypothalamic neurons in stress-induced breast cancer growth; multiple National Cancer Institute projects ($793 thousand for whole-body redox maps in metastatic prostate cancer, $770 thousand for sphingolipid synthesis in anti-tumor immunity); and $1.434 million from NSF's Division of Undergraduate Education for the DNA Observatory, a collaborative infrastructure project for undergraduate DNA sequencing research at partner institutions including James Madison University and the University of Georgia. Conference grants typically range from $200 thousand to $300 thousand and support meetings on cancer biology, neuroscience, aging, immunology, and genomics that convene 300–500 international researchers annually.

CSHL acts as subrecipient on grant work collaboratively with Johns Hopkins University (brain-body feedback loops in stress-induced metastasis), Stanford University (whole-brain circuit mapping using barcoded rabies virus), MIT (marmoset brain data analysis), Pennsylvania State University (tyrosine kinase evolutionary landscapes), UC Davis (sex-specific gene expression in adolescent brain development), and the Allen Institute (Brain Connects Data Coordination Center). The institution received $8 million in Congressional Directives funding (CFDA 93.493) in fiscal 2023 for facility construction and renovation.

Recent award completions include 56 grants reaching final completion dates within the next twenty-four months, representing moderate recompete activity centered on neuroscience, cancer, aging, and genomics research programs. The institution maintains no active federal contract vehicles; all federal support flows through competitive and collaborative grant mechanisms under NIH, NSF, and DoD funding lines, with emphasis on peer-reviewed research awards and congressionally directed STEM education and workforce development grants.